The main advantage of asynchronous teledermatology is the improvement of the quality triage, allowing the detection of malignant or suspicious lesions. However, we need more comparable studies on a larger scale to evaluate the disadvantages (photographic technique limitation, evaluation of other lesions, legal aspects, professional motivation...).
A girl younger than 2 years presented with a 7-month history of an inflammatory plaque on her left index finger (Figure , A). This lesion had started as a light erythema a few months before, initially oriented as a bacterial paronychia or herpetic whitlow and treated with an oral antibiotic (amoxicillin) and antiviral (acyclovir) without improvement. There was no relevant medical history. The family reported living in a rural area on the Mediterranean coast.Physical examination findings revealed an inflammatory erythematous plaque with a central shiny orange crust on the left index finger (Figure , B). No other fingers were affected. There were no systemic symptoms or family history of similar lesions. Given the chronic course, with no improvement with empiric therapy, a biopsy specimen was obtained for further evaluation (Figure, C and D). Erythematous nodule on proximal nail fold A Inflammatory erythematous plaque B Original magnification ×10 C Original magnification ×40 D Figure. A, Erythematous nodule on the proximal nail fold. B, Inflammatory erythematous plaque with a central shiny orange crust on the left index. C, Diffuse dermatitis with epithelioid granulomas (hematoxylin-eosin stain). D, Intracellular amastigotes in the dermal macrophages (hematoxylin-eosin stain).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.